Logo image of CSTR.CA

CRYPTOSTAR CORP (CSTR.CA) Stock Fundamental Analysis

TSX-V:CSTR - TSX Venture Exchange - CA22905W1095 - Common Stock - Currency: CAD

0.02  +0.01 (+33.33%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CSTR. CSTR was compared to 12 industry peers in the IT Services industry. CSTR may be in some trouble as it scores bad on both profitability and health. CSTR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CSTR had negative earnings in the past year.
In the past year CSTR has reported a negative cash flow from operations.
CSTR had negative earnings in each of the past 5 years.
In the past 5 years CSTR reported 4 times negative operating cash flow.
CSTR.CA Yearly Net Income VS EBIT VS OCF VS FCFCSTR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

With a Return On Assets value of -60.79%, CSTR is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
CSTR's Return On Equity of -124.73% is in line compared to the rest of the industry. CSTR outperforms 50.00% of its industry peers.
Industry RankSector Rank
ROA -60.79%
ROE -124.73%
ROIC N/A
ROA(3y)-62.9%
ROA(5y)-49.49%
ROE(3y)-108.9%
ROE(5y)-99.79%
ROIC(3y)N/A
ROIC(5y)N/A
CSTR.CA Yearly ROA, ROE, ROICCSTR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CSTR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CSTR.CA Yearly Profit, Operating, Gross MarginsCSTR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

3

2. Health

2.1 Basic Checks

CSTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
CSTR has more shares outstanding than it did 1 year ago.
CSTR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CSTR is higher compared to a year ago.
CSTR.CA Yearly Shares OutstandingCSTR.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CSTR.CA Yearly Total Debt VS Total AssetsCSTR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

CSTR has an Altman-Z score of -6.49. This is a bad value and indicates that CSTR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -6.49, CSTR is in line with its industry, outperforming 41.67% of the companies in the same industry.
A Debt/Equity ratio of 0.45 indicates that CSTR is not too dependend on debt financing.
The Debt to Equity ratio of CSTR (0.45) is better than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z -6.49
ROIC/WACCN/A
WACC8.33%
CSTR.CA Yearly LT Debt VS Equity VS FCFCSTR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

CSTR has a Current Ratio of 1.26. This is a normal value and indicates that CSTR is financially healthy and should not expect problems in meeting its short term obligations.
CSTR has a Current ratio of 1.26. This is comparable to the rest of the industry: CSTR outperforms 58.33% of its industry peers.
CSTR has a Quick Ratio of 1.26. This is a normal value and indicates that CSTR is financially healthy and should not expect problems in meeting its short term obligations.
CSTR's Quick ratio of 1.26 is fine compared to the rest of the industry. CSTR outperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.26
CSTR.CA Yearly Current Assets VS Current LiabilitesCSTR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.61% over the past year.
The Revenue for CSTR has decreased by -42.59% in the past year. This is quite bad
CSTR shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -26.83% yearly.
EPS 1Y (TTM)20.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-130.77%
Revenue 1Y (TTM)-42.59%
Revenue growth 3Y-23.99%
Revenue growth 5Y-26.83%
Sales Q2Q%-97.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CSTR.CA Yearly Revenue VS EstimatesCSTR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CSTR.CA Yearly EPS VS EstimatesCSTR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 -0 -0 -0.01 -0.01 -0.01

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CSTR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CSTR.CA Price Earnings VS Forward Price EarningsCSTR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CSTR.CA Per share dataCSTR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0 0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CSTR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CRYPTOSTAR CORP

TSX-V:CSTR (6/4/2025, 7:00:00 PM)

0.02

+0.01 (+33.33%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)04-29 2025-04-29
Earnings (Next)06-02 2025-06-02
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.47M
Analysts45.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.97
P/FCF N/A
P/OCF N/A
P/B 1.68
P/tB 1.68
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.01
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -60.79%
ROE -124.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-62.9%
ROA(5y)-49.49%
ROE(3y)-108.9%
ROE(5y)-99.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 1.26
Altman-Z -6.49
F-Score2
WACC8.33%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-130.77%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-42.59%
Revenue growth 3Y-23.99%
Revenue growth 5Y-26.83%
Sales Q2Q%-97.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y57.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.72%
OCF growth 3YN/A
OCF growth 5YN/A